Vertex Pharma's £1.65 million ($2.05 million) gene-editing therapy for sickle cell disease (SCD), Casgevy, has been given the green light for use by the NHS in England under a managed access ...

Novel Bone Marrow Transplant Can Cure Sickle Cell Disease, Study Suggests Feb. 25, 2025 — A bone marrow transplant process is safe and curative for adults with sickle cell disease, according to ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The present case demonstrates the often complex mechanism of anemia in alcoholics. The etiology included both reduced red blood survival and reduced red blood cell production (e.g. bone-marrow ...

Gene Modification Could Improve Cancer Treatment's Success Rate Feb. 7, 2025 — A research team has made a major discovery on how the CUL5 gene affects CAR-T cell therapy, an advanced cancer therapy.